Distributed

No. 17-936

Gilead Sciences, Inc. v. United States, ex rel. Jeffrey Campie, et al.

from the United States Court of Appeals for the Ninth Circuit

See other cases from the Ninth Circuit.

Docket Entries

The Solicitor General is invited to file a brief in this case expressing the views of the United States.

Reply of petitioner Gilead Sciences, Inc. filed. (Distributed)

Brief of respondents Jeffrey Campie, et al. in opposition filed.

Brief amicus curiae of Washington Legal Foundation filed.

Brief amicus curiae of ConocoPhillips Company filed.

Brief amicus curiae of CTIA - The Wireless Association filed.

Brief amici curiae of Pharmaceutical Research and Manufacturers of America; Biotechnology Innovation Organization filed.

Brief amicus curiae of Coalition for Government Procurement filed.

Brief amici curiae of Chamber of Commerce for the United States of America, et al. filed.

Motion to extend the time to file a response is granted and the time is extended to and including March 5, 2018.

Motion to extend the time to file a response from February 2, 2018 to March 5, 2018, submitted to The Clerk.

Blanket Consent filed by counsel for both Petitioner, Gilead Sciences, Inc. and Respondents Jeffrey Campie and Sherilyn Campie.

Petition for a writ of certiorari filed. (Response due February 2, 2018)

Parties

Gilead Sciences, Inc., Petitioner, represented by E. Joshua Rosenkranz

Jeffrey Campie, et al., Respondent, represented by Tejinder Singh

Amici Curiae

Chamber of Commerce for the United States of America, et al., Amicus Curiae, represented by John Patrick Elwood

Coalition for Government Procurement, Amicus Curiae, represented by Dan Himmelfarb

ConocoPhillips Company, Amicus Curiae, represented by Daryl Langdon Joseffer

CTIA - The Wireless Association, Amicus Curiae, represented by Nicole A. Saharsky

Pharmaceutical Research and Manufacturers of America; Biotechnology Innovation Organization, Amicus Curiae, represented by Douglas Harry Hallward-Driemeier

Washington Legal Foundation, Amicus Curiae, represented by Richard A. Samp

 
Last updated: October 18, 2018